share_log

多瑞医药(301075.SZ)发布一季度业绩,净亏损253.73万元,同比扩大4.97%

Dorui Pharmaceuticals (301075.SZ) announced first-quarter results, with a net loss of 2,5373 million yuan, an increase of 4.97% over the previous year

Zhitong Finance ·  Apr 24 06:24

Dorui Pharmaceuticals (301075.SZ) released its report for the first quarter of 2024, with revenue of 784.574 million...

According to the Zhitong Finance App, Dorui Pharmaceutical (301075.SZ) released its report for the first quarter of 2024, with operating income of 784.574 million yuan, up 0.48% year on year; net loss attributable to shareholders of listed companies was 2,5373 million yuan, up 4.97% year on year; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 3.7493 million yuan, up 1.4% year on year; basic loss per share was 0.03 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment